Clinical Trials Directory

Trials / Unknown

UnknownNCT05739084

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

[RADIOSARC] Searching for Specific Gene Signature(s) of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Adults Patients With Resectable Soft Tissue Sarcomas of Limbs

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Centre Leon Berard · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To date, the radiation oncologist are missing biomarkers predictive of response/resistance to RT in order to identify patients who may benefit from RT and personalize the RT schedule. Our proposal is to conduct a cohort study aiming at identifying transcriptomic biomarkers predictive of sensitivity and/or resistance to RT in limbs STS patients

Detailed description

Whether RT should be performed pre or post-operatively is still a debated question. To date, the radiation oncologist are missing signature of response/resistance to RT in order to identify patients who may benefit from RT and personalize the RT schedule. Therefore, predicting the likelihood of response/resistance to RT is essential. The individual exploration with high-throughput approaches will participate in describing biological mechanisms involved in STS tumor cell pan-resistance, thus identifying potential molecular targets that could be inhibited to reverse intrinsic radioresistance. In this context, our proposal is to conduct a cohort study aiming at identifying transcriptomic signature predictive of sensitivity and/or resistance to RT in limbs STS patients.

Conditions

Interventions

TypeNameDescription
RADIATIONpre-operative radiationAs per standard of care and institutional guidelines
PROCEDUREStandard surgery after rpreoprative radiationAs per standard of care and institutional guidelines

Timeline

Start date
2022-11-23
Primary completion
2025-06-23
Completion
2025-11-23
First posted
2023-02-22
Last updated
2023-02-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05739084. Inclusion in this directory is not an endorsement.